InsiderClue
← All stocks

Nuvectis Pharma, Inc.

NVCT Net buying
CIK 0001875558 #2767 in the set updated 17 Sep 2026
Bought (120 mo)
$10.61M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$22.48K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$22.48K
1 of 1 sales
Net
+$10.59M
+$10.59M against sales at will

By person

9 insiders · 146 transactions
28.4×

Ron Bentsur holds 28.4 times base salary in stock. $73.77M of shares against $2.59M in salary for 2025.

Salary from the company's own proxy. The shares are what Ron Bentsur last reported holding, valued at $20.00, the price Common Stock was last bought or sold at on the open market here, on 30 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mosseri Marlio Charles
10% owner
$7.44M (38)
—
+$7.44M
5,798,576
17.80%
$115.97M
+15.2%
BENTSUR RON
Chairman & CEO
$2.73M (77)
—
+$2.73M
3,688,424
11.32%
$73.77M
+43.8%
Kaplan Matthew L.
Director
$114.87K (3)
—
+$114.87K
159,760
0.4903%
$3.20M
+387.7%
Hoberman Kenneth
Director
$104.40K (1)
—
+$104.40K
168,140
0.5161%
$3.36M
+242.2%
Shemesh Shay
Chief Dev. & Ops. Officer
$94.52K (18)
—
+$94.52K
1,793,068
5.50%
$35.86M
+52.4%
Sanchez Juan
Director
$75.27K (1)
—
+$75.27K
113,380
0.3480%
$2.27M
+220.5%
Poradosu Enrique
Chief Science & Business Off
$45.01K (7)
—
+$45.01K
1,806,319
5.54%
$36.13M
+51.4%
Carson Michael J.
Vice President, Finance
—
$22.48K (1)
−$22.48K
230,118
0.7063%
$4.60M
+742.9%
Oliviero James F III
Director
—
—
—
122,828
0.3770%
$2.46M
+1,150%

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
Carson Michael J.
7 Nov 2024
Vice President, Finance
Sell
2,755
$8.16
$22.48K
Show all 146 transactions →

What was left out

Form 4 filings counted 128
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,549,573
History held since 8 Feb 2022